Oppenheimer Asset Management Inc. Exact Sciences Corp Transaction History
Oppenheimer Asset Management Inc.
- $8.4 Billion
- Q2 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 19,549 shares of EXAS stock, worth $1.24 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,549
Previous 18,147
7.73%
Holding current value
$1.24 Million
Previous $785,000
32.23%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding EXAS
# of Institutions
657Shares Held
159MCall Options Held
1.43MPut Options Held
2.35M-
Capital World Investors Los Angeles, CA18.2MShares$1.15 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.13 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$763 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$759 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$340 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.2B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...